COMPANY PROFILE · UPDATED 18 NOV 2025

Veracyte

Veracyte, Inc. develops molecular tests for oncology. The Company offers molecular cytology and tests for the diagnostic accuracy of cytology samples. Veracyte provides its products and services to healthcare and molecular diagnostic…

www.veracyte.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2006
Headcount: 389
Open roles: 28
Last raised: Post Ipo Equity · Sign in to view

TECH STACK

How Veracyte builds

Extracted from Veracyte’s job postings we’ve tracked

Cloud Platforms

Amazon Web Services×13 Amazon S3×3 AWS Lambda×3 Google Cloud×3 Microsoft Azure×3 Amazon ECS×2 Amazon EKS×2

Other Software & Platforms

Microsoft Office×15

Programming Languages

Python×9 Bash×2 PowerShell×2

DevOps & Infrastructure

Docker×3 Docker/Kubernetes×3 Linux×3 Windows×3

CRM & Sales Tools

Salesforce×10

Databases

SQL×4 Microsoft SQL Server×2

Frameworks & Libraries

CMS×3

Analytics & BI

Microsoft Excel×3

LEADERSHIP

Founders & key people

OPEN ROLES

Hiring at Veracyte

View all 28 open roles →

FUNDING

Capital raised

Total raised

$1,098,150,016

Investors

Kleiner PerkinsArmentum PartnersDomain AssociatesGE VenturesMadryn Health Partners (Cayman Feeder)TPG BiotechVersant Ventures

Funding rounds

Post Ipo Equity
$550MFeb 4, 2021
Post Ipo Equity
$194MAug 4, 2020
Post Ipo Equity
$137.8MApr 30, 2019
Post Ipo Equity
$55.1MJul 24, 2018
Post Ipo Equity
$30MNov 1, 2016
Post Ipo Debt
Madryn Health Partners (Cayman Feeder)
$45MMar 28, 2016
Debt Financing
Armentum Partners
$15MDec 31, 2013
Series C
GE Ventures, Kleiner Perkins, TPG Biotech, Domain Associates, Versant Ventures
$28MJun 27, 2013
IPO
UndisclosedJan 1, 2013
Series Unknown
Domain Associates, Kleiner Perkins
$15MSep 30, 2012
Series B
Domain Associates, TPG Biotech, Kleiner Perkins, Versant Ventures
$28MJun 10, 2010
Series A
$300KDec 20, 2006